Anaemia is a common cause of B12 or folate deficiency where there are fewer red blood cells or a lower amount of haemoglobin, which helps the blood carry oxygen around the body
Hypokalemia: In extremely rare cases, B12 injections may lead to low potassium levels in the blood, known as hypokalemia
WADA Prohibition The World Anti-Doping Agency explicitly prohibits AOD-9604 for competitive athletes: Listed under Section S0 (Non-Approved Substances) and S2.2.3 (Growth Hormone Fragments) Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions (TUEs) available Detection methods developed and implemented in anti-doping laboratories worldwide WADAs 2013 statement clarified that AOD-9604 is a substance still under pre-clinical and clinical development and has not been approved for therapeutic use by any government health authority in the world. Research Classification: AOD-9604 is available only for laboratory research use
For those seeking a non-surgical alternative to procedures like liposuction, AOD9604 provides an equally effective solution without the risks and recovery time associated with invasive treatments
Fluid Retention: Full GH therapy commonly causes fluid retention, edema, and associated complications including carpal tunnel syndrome
In more severe cases, a Vitamin-B deficiency can result in nerve damage, anemia and stomach complications